-transparent.png){kind=logo}
Agranulocytosis developed in a patient who was receiving propylthiouracil. Using a microgranulocytotoxicity assay, serum taken from the patient was shown to be strongly granulocytotoxic when tested against the patients granulocytes and those obtained from two of eight normal subjects. Tests for granulocyte agglutinins and for lymphocytotoxicity were negative. Granulocytotoxic activity decreased as the patient's peripheral granulocyte count recovered. Cytotoxicity was shown to be mediated by a complement-dependent IgM antibody.
Related Publications
M M Guffy, and
N E Goeken, and
C P Burns
October 1982,
Klinische Wochenschrift,
M M Guffy, and
N E Goeken, and
C P Burns
November 1980,
Ugeskrift for laeger,
M M Guffy, and
N E Goeken, and
C P Burns
December 2005,
The Korean journal of internal medicine,
M M Guffy, and
N E Goeken, and
C P Burns
January 2011,
Internal medicine (Tokyo, Japan),
M M Guffy, and
N E Goeken, and
C P Burns
January 2023,
International medical case reports journal,
M M Guffy, and
N E Goeken, and
C P Burns
January 2020,
Endocrinology, diabetes & metabolism case reports,
M M Guffy, and
N E Goeken, and
C P Burns
July 2019,
Revista da Associacao Medica Brasileira (1992),
M M Guffy, and
N E Goeken, and
C P Burns
October 2014,
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
M M Guffy, and
N E Goeken, and
C P Burns
February 1952,
Journal of the American Medical Association,
M M Guffy, and
N E Goeken, and
C P Burns
December 1991,
JAMA,
